Marie Marklund1, Karl A Franklin. 1. Department of Orthodontics, Umeå University, 901 87, Umeå, Sweden, marie.marklund@odont.umu.se.
Abstract
INTRODUCTION: The simplicity of oral appliance therapy in the treatment of adult patients with snoring and obstructive sleep apnea (OSA) has resulted in a worldwide interest for this treatment modality. Mandibular advancement devices (MADs) that hold the lower jaw forward during sleep are mainly indicated for patients with milder OSA and those with CPAP intolerance. There has been minor attention on age when suggesting treatment alternatives for patients with OSA. Some studies indicate that there is a weak negative relationship between treatment success from MADs and higher age, but no studies have stratified their samples with respect to age. OBJECTIVE: The present aim was to compare the effects and side effects from MADs between an elderly group of patients (>65 years of age) and a younger age group that were extracted from two of our previous studies. RESULTS: The results showed no difference between the elderly and the younger patients in success rate or the degree of bite changes from MAD treatment. CONCLUSION: These findings indicate that MADs represent an alternative to CPAP irrespective of the age of the patient.
INTRODUCTION: The simplicity of oral appliance therapy in the treatment of adult patients with snoring and obstructive sleep apnea (OSA) has resulted in a worldwide interest for this treatment modality. Mandibular advancement devices (MADs) that hold the lower jaw forward during sleep are mainly indicated for patients with milder OSA and those with CPAP intolerance. There has been minor attention on age when suggesting treatment alternatives for patients with OSA. Some studies indicate that there is a weak negative relationship between treatment success from MADs and higher age, but no studies have stratified their samples with respect to age. OBJECTIVE: The present aim was to compare the effects and side effects from MADs between an elderly group of patients (>65 years of age) and a younger age group that were extracted from two of our previous studies. RESULTS: The results showed no difference between the elderly and the younger patients in success rate or the degree of bite changes from MAD treatment. CONCLUSION: These findings indicate that MADs represent an alternative to CPAP irrespective of the age of the patient.
Authors: W J Randerath; J Verbraecken; S Andreas; G Bettega; A Boudewyns; E Hamans; F Jalbert; J R Paoli; B Sanner; I Smith; B A Stuck; L Lacassagne; M Marklund; J T Maurer; J L Pepin; A Valipour; T Verse; I Fietze Journal: Eur Respir J Date: 2011-03-15 Impact factor: 16.671
Authors: Francois-Xavier Petit; Jean-Louis Pépin; Georges Bettega; Hazem Sadek; Bernard Raphaël; Patrick Lévy Journal: Am J Respir Crit Care Med Date: 2002-08-01 Impact factor: 21.405